MDMA, sold as “ecstasy” or “molly,” is known for feelings of closeness, energy, and empathy. In clinical research it is being studied for PTSD (Articles 11 and 22). In nightlife settings it is used recreationally, and the street product is unpredictable. This article explains how it affects the body and the main risks.

How it works

MDMA causes a large release of serotonin, along with dopamine and norepinephrine. This produces elevated mood, emotional openness, heightened sensation, and energy. It also raises heart rate, blood pressure, and body temperature, and it causes jaw clenching, sweating, and reduced appetite.

Main risks in the moment

Overheating. MDMA raises body temperature, and dancing in a hot, crowded space makes it worse. Severe overheating (hyperthermia) is one of the leading causes of serious harm and death. Signs include very hot skin, confusion, muscle rigidity, and collapse. This is a medical emergency.

Too much water. In reaction to warnings about dehydration, some people drink excessive amounts of water. MDMA also causes the body to retain water, and drinking far more than needed can dilute blood sodium (hyponatremia), leading to headache, nausea, confusion, seizures, and swelling of the brain. The message from harm-reduction groups is balance: sip when thirsty, take breaks to cool down, and don’t force fluids.

Serotonin syndrome. Combining MDMA with other serotonergic drugs can cause a dangerous overload. Medications of concern include MAOIs (a class of antidepressants), and to some degree SSRIs and some other antidepressants, certain pain medications, and other recreational drugs. Symptoms include agitation, fever, rapid heartbeat, tremors, and muscle rigidity. Seek emergency help.

Heart strain. People with heart conditions or high blood pressure face higher risk.

Anxiety and panic. Some people have distressing experiences, particularly in unfamiliar environments.

Unpredictable street product. Pills and powders sold as MDMA often contain other substances, including cathinones, stimulants, or in some cases more dangerous compounds. Fentanyl contamination has been found in unregulated stimulants. Drug checking helps but cannot guarantee safety.

The comedown

After the effects fade, many people feel low, tired, irritable, or anxious for a few days, sometimes called the “midweek blues.” Contributing factors include serotonin depletion, poor sleep, dehydration, and poor nutrition. Eating, resting, and being with supportive people helps. If low mood is severe or persistent, or if you have thoughts of harming yourself, seek help; in Canada you can call or text 9-8-8.

Long-term considerations

Frequent, heavy use over time has been associated with memory difficulties, mood problems, and sleep disruption in some studies, although research is complicated by multi-drug use and other factors. Spacing out use and avoiding frequent use are consistent harm-reduction recommendations.

Who should be especially careful

• People with heart conditions, high blood pressure, or epilepsy
• People taking antidepressants, MAOIs, or other prescription medicines
• People with a history of serious mental illness
• People with liver or kidney conditions
• Anyone who is pregnant

Harm reduction principles

• Test your substance where possible, and understand that tests can’t confirm safety.
• Don’t use alone; stay with friends who will look out for you.
• Avoid mixing with alcohol and other drugs, which adds risk and increases dehydration and heat strain.
• Manage heat: take breaks in cool areas, wear light clothing, and watch for signs of overheating.
• Drink sensibly, not obsessively.
• Don’t treat repeated use or topping up as harmless; more does not mean better, and higher exposure raises risk. Detailed guidance on this is available at DanceSafe and TripSit.
• Plan for aftercare: sleep, food, and time off before work or study.
• Keep naloxone if there’s any chance of opioid contamination, and know when to call for help.

Emergency signs

Call emergency services for: very high body temperature, confusion, seizures, collapse, unresponsiveness, severe headache with vomiting, or trouble breathing.

Clinical MDMA is different

The trials described earlier in this series used pharmaceutical-grade MDMA, screening, trained therapists, and monitoring. Results from those trials do not tell us how safe or effective street MDMA is.

The takeaway

MDMA’s main dangers are overheating, too much fluid, interactions with other drugs and medications, and unknown contents. Awareness, moderation, and looking out for friends make a real difference.

Sources: General pharmacology and harm-reduction guidance; MAPP trial literature for the clinical comparison. Verify against DanceSafe and TripSit.